Emboldened By Scrapie Campaigns, German Newcomer Puts Orchid Cellmark in Crosshairs | GenomeWeb

In a small German port city on the North Sea coast, the 15 men and women who make up GAG Bioscience are gearing up to take on the industry leader in scrapie-susceptibility genotyping.

The tiny company, based in Bremen, hopes its mass spectrometry-based genotyping technology will catch up to Orchid Biosciences’ technology as the preeminent platform for eradicating scrapie from the world’s sheep population, and will help animal-health officials breed resistant sheep.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.